I am a radiologist who specializes in diagnostic imaging and nuclear medicine. I completed my clinical training at The Ohio State University and Mallinckrodt Institute of Radiology in St. Louis, which defined an academic career pathway for me. In 2012, I joined the Department of Radiology at Ohio State as an assistant professor in the Division of Nuclear Medicine and Molecular Imaging.
I am also a member of the Translational Therapeutics Program at the OSUCCC – James, where my research focuses on the development and assessment of new imaging technologies and agents related to next-generation positron emission tomography (PET) technologies, PET imaging for theranostics and clinical trials using nuclear medicine methodologies.
Since my arrival, I have worked closely with my mentor, Michael V. Knopp, MD, PhD, on novel concepts for theranostic Yttrium-90 imaging, as well as the clinical development of a next-generation, digital photon counting PET system that we operate at the Wright Center of Innovation in Biomedical Imaging at Ohio State. This effort is supported by the National Cancer Institute (NCI) Clinical Loan Repayment Program. In addition, I actively participate in the Imaging Core Laboratory for the NCI's National Clinical Trials Network.
- Named to the Castle Connolly list of “Regional Top Doctors,” 2018-2019
Procedures and Conditions I Treat
- Diagnostic Imaging
- Nuclear Medicine
- Positron-Emission Tomography
- Cardiac Imaging Techniques
- Tomography, Emission-Computed, Single-Photon
Education and Training
Ohio State University College of Medicine, Columbus, OH
6/1/1997 - 6/11/2006
Riverside Methodist Hospital, Columbus, OH
7/1/2006 - 6/30/2007
Ohio State University Wexner Medical Center, Columbus, OH
7/1/2007 - 6/30/2011
Washington University Hospital, St. Louis, MO
7/1/2011 - 6/30/2012
American Board of Radiology (Subspecialty: Diagnostic Radiology)
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 11/21/2019, Dr. Wright has reported no relationships with companies or entities.